loading
Radiesse is an injectable dermal filler made of calcium hydroxylapatite (CaHA) microspheres suspended in a gel carrier. Known for firm, structural support and a collagen-stimulating effect, it is often discussed for the jawline, chin, and the backs of the hands—and unlike hyaluronic acid fillers, it cannot be dissolved with an enzyme.
Radiesse belongs to the broad family of injectable fillers, but its material sets it apart from the more familiar hyaluronic acid (HA) products. The CaHA microspheres give the injected area an immediate, relatively firm lift, which is why it is commonly considered for the jawline, chin, cheeks, and nasolabial folds, as well as the backs of the hands, where volume loss makes tendons and veins more visible. Whether a given site is appropriate should be confirmed in consultation, based on the registered indications of the specific product being used.
It can restore lost volume and give a soft contour a crisper line, and because the material also stimulates collagen, part of the result develops gradually. It does not tighten loose skin the way energy-based or surgical procedures do, cannot reposition sagging tissue like a facelift, and is generally not used in the lips or the thin skin around the eyes, where a firm filler is more likely to leave visible or palpable lumps.
After injection, the gel carrier provides most of the immediate volume, so a change is visible right away. Over the following weeks the carrier is gradually absorbed, while the CaHA microspheres act as a scaffold around which the body builds its own collagen; the microspheres themselves are slowly broken down and metabolized. In this collagen-stimulating respect it is sometimes compared with poly-L-lactic-acid injectables, though the materials and textures differ. The result therefore evolves over time rather than being fixed on day one.
At the appointment, the injector reviews your medical history, plans and marks the injection points, and disinfects the skin; topical numbing or a local anesthetic mixed into the product may be used. Injection itself typically brings pressure, stinging, and a sensation of fullness. Immediately afterward the area is often swollen, slightly red, and tender, sometimes with bruising. The new contour is visible at once and settles over one to two weeks as swelling resolves, while the collagen-related portion of the result builds gradually over the following months.
A typical candidate is an adult bothered by a softening jawline, a receding chin profile, mid- or lower-face volume loss, or aging-looking hands, who wants a firmer, more structural correction than a soft HA filler tends to give. A worthwhile consultation should cover why CaHA rather than HA suits your goal, exactly where it will and will not be placed, what the lack of a dissolving enzyme means for your plan, what result is realistic on your face or hands, and the injector's qualifications and experience with this specific material.
It is not for everyone. Injection should be avoided during pregnancy and breastfeeding, over active infection or inflammation at the treatment site, and in people with known hypersensitivity to the ingredients. Bleeding disorders, anticoagulant or antiplatelet medication, a history of severe allergies or keloid scarring, and permanent fillers previously placed in the same area all need to be disclosed and weighed. First-time filler patients who want the option of reversal are often advised to consider a dissolvable HA product instead.
Swelling, redness, bruising, tenderness, itching, and a firm or slightly lumpy feeling are common in the first days and usually settle within one to two weeks; hand injections tend to swell more noticeably and for longer. Because filler injection is a medical procedure, it should only be performed at a licensed medical institution by a physician qualified and experienced in injectables—the setting and the injector matter as much as the product itself.
Less common problems include persistent nodules, granulomas, infection, and material placed too superficially showing through as whitish bumps. The most serious risk shared by all fillers is accidental injection into a blood vessel, which can cause skin necrosis or, rarely, vision loss, and requires emergency care. Critically, unlike HA fillers there is no enzyme that can dissolve CaHA—hyaluronidase does not work on it—so an unsatisfactory result or a complication cannot simply be melted away; it must be managed by other means or waited out as the material metabolizes over many months.
Contact the treating clinician promptly if pain keeps intensifying, the skin turns pale or dusky or develops a net-like discoloration, blisters or ulcers appear, vision changes in any way, or a lump becomes red, warm, and painful weeks after treatment. This article is general information only; it is not medical advice and cannot replace an in-person assessment by a qualified physician.